BSECompany Update1 Oct 2026 · 1 Oct 2026, 11:35 am
Cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director of the company upon completion of his second term of appointment as an Independent Director
KMS Medisurgi Ltd · 540468
✦ AI SummaryMgmt Change
KMS Medisurgi Ltd announces the cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director, effective September 30, 2026, upon completion of his second term.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
KMS Medisurgi Ltd - 540468 - Announcement under Regulation 30 (LODR)-Cessation
Attachments (1)
📄pdf
Download →
0ccd91d0-0d7e-4a0d-8330-f911fd8c1124.pdf
View document text
KMS MEDISURGI LIMITED
® Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street,
Mumbai 400 002 Maharashtra (India)
™ J CIN: L51397MH1999PLC119118
Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com
Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400001
Ref.: KMS Medisurgi Limited (Scrip Code: 540468)
Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 - Intimation regarding cessation of Independent Director
Dear Sir/Madam,
Pursuant to Regulation 30 read with Schedule Ill of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby
inform you that Mr. Kamlesh Rajani Chunilal (DIN: 07588417) has completed his second term as an
Independent Director of the Company and, consequently, has ceased to be a Director of the Company
with effect from the close of business hours on September 30, 2026.
The Board of Directors and the Management of the Company place on record their sincere
appreciation for the valuable contributions, guidance and services rendered by Mr. Kamlesh Rajani
Chunilal during his tenure as an Independent Director of the Company.
The requisite details regarding the aforesaid cessation of the Independent Director, as prescribed
under Clause 7 of Para A of Part A of Schedule Ill of the SEBI Listing Regulations, read with the SEBI
Circular dated July 13, 2023, are enclosed herewith as Annexure A.
The above information is also available on the website of the Company at www.kmsgroup.in.
You are requested to kindly take the above information on record.
Thanking you,
Yours faithfully,
For KMS MEDISURGI LIMITED
w DIRECTOR
Siddharth Kanakia
Managing Director
DIN: 07595098
Place: Mumbai
Date: October 01, 2026
ANNEXUR-E A
Details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, read with the SEBI Circulars dated July 13, 2023 and November 11, 2024
Cessation of Mr. Kamlesh Rajani Chunilal (DIN: 07588417) as Independent Director of the Company
Name of Director Mr. Kamlesh Rajani Chunilal (DIN:
07588417)
Reason for Change (cessation) Cessation of Mr. Kamlesh Rajani Chunilal as
an Independent Director of the Company
upon completion of his second term of
appointment as an Independent Director.
Date of Cessation September 30, 2026
Disclosure of relationship between directors | Not Applicable
Directorship in any other listed companies Nil
Board Committee Update Nil
Information required pursuant to BSE Circular | Not Applicable
no. LIST/COMP/14/2018-19 and the NSE
Circular no. NSE/ CML/2018/24, both dated
20 June 2018